Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Mitragynine Topical Patch From Kratom for Pain Reduction in Myofascial Pain Syndrome
NCT07713771Phase 3Not yet recruiting
- Sponsor
- Prince of Songkla University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mitragynine in myofascial pain syndrome (MPS) (2 arms), sponsored by Prince of Songkla University. Primary endpoint: Pain Score at 3 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
mitragynine
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07713771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07713771.